Table 1. Details on the 48 samples selected from the Vi-DT phase 1 study for Vacczyme ELISA.

Anti-Vi IgG Age group	Low	Medium	High	Total
Adults (18–45 yrs)	5	5	5	15
Adolescents (6–17 yrs)	4	6	6	16
Children (2–5 yrs)	5	7	5	17
Total	14	18	16	48

* Anti-Vi IgG (μg/ml) < 20.279 (Low); ≥20.279 and <51.143 (Medium); ≥51.143 (High).